글로벌 Pingueculum 약물 시장 – 2029년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Pharmaceutical Global Pingueculum Drugs Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

글로벌 Pingueculum 약물 시장 – 2029년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Nov 2022
  • Global
  • 350 Pages
  • 테이블 수: 647
  • 그림 수: 77
지금 구매 지금 구매

>글로벌 핑게쿨룸 약물 시장, 치료별(인공 눈물/국소 윤활제 , 스테로이드 점안액, 비스테로이드성 항염제 점안액 및 기타), 제형 유형(점안액, 눈 연고 및 기타), 구매 방식(처방전, 일반 의약품(OTC)), 약물 유형(브랜드 및 제네릭), 인구 유형(노인 및 성인), 최종 사용자(병원, 전문 병원, 재택 의료 및 기타), 유통 채널(병원 약국, 소매 약국, 온라인 약국 및 기타) - 업계 동향 및 2029년까지의 예측.

핑게쿨룸 약물 시장

Pingueculum 약물 시장 분석 및 통찰력

결막 결막증은 악성이 아닌 전형적인 결막 성장입니다. 결막 결막증 진행의 위험 요인에는 자외선 노출, 외상, 바람, 먼지 및 모래, 장시간 야외 작업 및 노화가 포함됩니다.

핑게쿨룸 약물 시장

핑게쿨룸 약물 시장

글로벌 핑게쿨럼 약물 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 지리적 확장 및 시장의 기술 혁신에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

Data Bridge Market Research에 따르면 글로벌 핑게쿨룸 약물 시장은 2022년부터 2029년까지의 예측 기간 동안 7.3%의 CAGR로 성장할 것으로 분석됩니다.

보고서 메트릭

세부

예측 기간

2022년부터 2029년까지

기준 연도

2021

역사적 연도

2020 (2014-2019로 사용자 정의 가능)

양적 단위

수익은 백만 달러, 가격은 미화로 표시됨

다루는 세그먼트

치료별(인공 눈물/국소 윤활제, 스테로이드 안약, 비스테로이드성 항염제 및 기타), 제형 유형(안약, 안연고 및 기타), 구매 방식(처방전, 일반의약품(OTC)), 약물 유형(브랜드 및 제네릭), 인구 유형(노인 및 성인), 최종 사용자(병원, 전문 병원, 가정 의료 및 기타), 유통 채널(병원 약국, 소매 약국, 온라인 약국 및 기타)

적용 국가

미국, 캐나다, 멕시코, 러시아, 스페인, 터키, 독일, 이탈리아, 영국, 프랑스, ​​헝가리, 오스트리아, 스위스, 네덜란드, 폴란드, 아일랜드, 노르웨이, 리투아니아, 유럽의 나머지 지역, 중국, 일본, 한국, 인도, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 베트남, 아시아 태평양의 나머지 지역, 브라질, 아르헨티나, 페루, 남미의 나머지 지역, 남아프리카, 사우디 아라비아, UAE, 이집트, 이스라엘, 쿠웨이트, 중동 및 아프리카의 나머지 지역

시장 참여자 포함

Alcon Inc., Johnson & Johnson Services, Inc., Novartis AG, Akorn Operating Company LLC, Bausch & Lomb Incorporated, AbbVie Inc., Prestige Consumer Healthcare Inc., Spectra Vision Care, Théa Laboratories, Wellona Pharma, SAGER PHARMA, Maya Biotech Private Limited, EYERIS VISIONCARE Pvt. Ltd., Sylentis, Bayer AG, Zydus Group, Amneal Pharmaceuticals LLC, OASIS Medical, Similasan Corporation, Alcon and Santen Pharmaceutical Co., Ltd.

시장 정의

결막낭종은 악성이 아닌 전형적인 결막 종양입니다. 이것은 눈의 흰자위(강막)를 둘러싼 투명하고 섬세한 조직입니다. 결막낭종이라는 단어는 "지방" 또는 "기름"을 의미하는 라틴어 단어 pinguis에서 유래했습니다. 결막낭종은 눈을 떴을 때 노출되는 결막 부분에서 발생합니다. 결막낭종 진행의 위험 요인에는 자외선 노출, 외상, 바람, 먼지 및 모래, 장시간 야외 작업 및 노화가 포함됩니다. 자외선 노출 병력이 있거나 적도에 더 가깝게 사는 사람은 발병률이 더 높습니다(야외 작업). 특정 연구에 따르면 남성의 발병률이 여성보다 다소 높은데, 이는 단순히 자외선 노출률이 더 높기 때문일 수 있습니다. 각막 근처 결막에 작고 황색을 띤 융기로 나타납니다. 각막의 양쪽에 나타날 수 있습니다.

글로벌 핑게쿨럼 약물 시장 역학

이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래와 같이 자세히 논의됩니다.

  • 핑궤양 장애 및 눈 통증의 유병률 증가

2020년 ULAKBİM 저널 시스템에서 발행한 "터키 서부의 핑게큘라 유병률 및 관련 요인"이라는 논문에 따르면, 이 연구에는 터키 서부의 20세 이상 개인 1443명이 포함되었으며, 이 중 52.5%가 핑게큘라를 앓고 있는 것으로 나타났고, 그 52.5% 중 핑게큘라 유병률은 여성(46.8%)보다 남성(58.4%)에서 더 높았습니다.

핑게쿨라 질환의 유병률은 전 세계적으로 여러 환경적 및 외부적 요인으로 인해 급증하는 모습을 보이고 있습니다. 화학 화상과 플래시 화상은 눈 표면의 자극으로 인해 심각하고 심한 눈 통증을 유발합니다. 따라서 핑게쿨라 장애와 눈 통증의 유병률이 증가함에 따라 예측 기간 동안 글로벌 핑게쿨라 약물 시장이 주도될 것으로 예상됩니다.

  • 오존층 파괴로 인한 만성 자외선 노출 증가

2019년 "시각 및 안과학 연구 협회"에서 발행한 저널에 따르면, 초기 결막염은 측두 결막에서 39.5%, 비강 결막에서 43.9%의 유병률을 보였다고 밝혔습니다. 야외 활동에 소요된 시간이 2시간 미만인 경우 19.6%와 16.1%, 4~6시간인 경우 44.7%와 52.2%, 6시간 이상인 경우 두 시야 모두 75.0%로, 결막염 유병률과 야외 활동 및 자외선 노출 시간 사이에 양의 상관관계가 있음을 나타냅니다.

UV 노출 증가와 핑게쿨라 유병률 증가 사이에는 상관관계가 있습니다. 이는 핑게쿨라 유병률과 햇빛 노출 사이에 연관성이 있음을 보여줍니다. 오존층 결함은 또한 UV 노출 증가로 이어져 핑게쿨라 장애 유병률이 증가하고 있습니다. 따라서 글로벌 핑게쿨라 약물 시장 성장을 주도할 것으로 예상됩니다.

  • 안구 질환 유병률 감소를 위한 이니셔티브 및 계획

2020년에 VISION 2020: 시력에 대한 권리 이니셔티브는 1999년 스위스 제네바의 세계보건기구(WHO)와 영국 런던의 국제실명예방기구(IAPB)에 의해 도입되었습니다. 유럽 이니셔티브 VISION2020은 2020년까지 피할 수 있는 실명을 종식시키고 피할 수 있는 시각 장애의 주요 원인에 초점을 맞춥니다.

CDC(질병통제예방센터)의 기사에 따르면, CDC는 2022년에 시력 건강 이니셔티브(VHI)와 다양한 이해 관계자를 통해 실명과 시력 장애를 예방하기 위한 조정된 국가적 공중 보건 프레임워크를 시작했습니다.

이러한 이니셔티브와 계획은 시장에 기회로 작용하고 있습니다. 따라서 눈 질환의 유병률을 낮추기 위한 이니셔티브와 계획은 글로벌 핑게쿨럼 약물 시장의 성장에 기회로 작용할 것으로 예상됩니다.

제약/도전

  • 스테로이드 안약의 부작용

경증에서 중증의 핑궤양 환자는 철저한 검사와 신속한 치료를 위해 안과 의사나 검안사를 추천합니다. 대부분 국소 열대 스테로이드, 열대 면역 조절제, 윤활 연고, 젤 또는 방울을 사용하여 치료합니다.

핑게쿨룸 약물 시장

프레드니솔론은 눈의 통증을 치료하는 데 가장 자주 사용되는 국소 스테로이드입니다. 프레드니솔론 아세테이트 안과용 현탁액은 아래에 언급된 일반적인 부작용이 있습니다.

  • 이 약을 사용한 후 1~2분 동안 눈이 따갑거나 화끈거리거나 가려움증이 발생합니다.
  • 시야가 일시적으로 가려짐
  • 빛에 대한 민감도 증가
  • 시각적 변화
  • 눈에 이물질이 들어간 경우
  • 알레르기 반응
  • 눈 치료를 위한 의료 시설 부족

IntechOpen 2020 보고서에 따르면 고소득 국가의 실명 및 안구 질환 유병률은 1000명당 0.3명이지만 저소득 국가의 경우 1000명당 1.5명으로 추산됩니다. 이는 저소득 국가에서 안과 치료에 대한 충족되지 않은 요구 사항을 보여줍니다.

저소득 국가의 또 다른 주요 문제는 눈의 통증 및 기타 장애에 대한 인식 부족입니다. 많은 연구 조사에서 저소득 국가에서 눈 건강 관리에 대한 요구가 높고 충족되지 않은 요구 사항이 여전히 많은 의료 기관에서 주목을 받고 있다고 보고합니다. 따라서 저소득 및 중소득 국가에서 눈 치료를 위한 열악한 의료 시설은 글로벌 핑게쿨럼 약물 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.

COVID-19 이후 글로벌 Pingueculum 약물 시장에 미치는 영향

COVID-19는 시장에 부정적인 영향을 미쳤습니다. 팬데믹 동안의 봉쇄와 격리는 질병 관리와 약물 복용을 복잡하게 만듭니다. 일상적인 치료와 약물 투여를 위한 의료 시설에 대한 접근성 부족은 시장에 더 큰 영향을 미칠 것입니다.

최근 개발 사항

  • 2022년 5월, Alcon은 Kala Pharmaceuticals, Inc.로부터 EYSUVIS(loteprednol etabonate suspension) 제약용 점안액 인수를 발표했습니다. 이 인수는 방부제가 없는 제형을 포함한 회사의 Systane 점안액 제품군을 보완할 것입니다.
  • 2022년 9월, Johnson & Johnson Vision Care, Inc.는 새로운 혁신인 Acuvue Oasys Max-day 콘택트 렌즈와 노안용 다초점 콘택트 렌즈 출시를 발표했습니다. 또한, 이 새로운 콘택트 렌즈는 디지털로 강렬한 라이프스타일을 충족하는 새로운 기술을 탑재했습니다.

글로벌 핑게쿨럼 약물 시장 범위

글로벌 핑게쿨럼 약물 시장은 약물 유형, 치료, 제형, 구매 방식, 인구 유형, 최종 사용자 및 유통 채널을 기준으로 7개의 주요 세그먼트로 분류됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 귀중한 시장 개요와 시장 통찰력을 제공하여 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 됩니다.

치료

  • 인공눈물/국소 윤활제
  • 스테로이드 눈약
  • 비스테로이드성 눈약
  • 기타

글로벌 핑게쿨룸 약물 시장은 치료에 따라 인공눈물/국소 윤활제, 스테로이드 안약, 비스테로이드 안약 및 기타로 구분됩니다.

제형 유형

  • 눈약
  • 눈 연고
  • 기타

글로벌 핑게쿨룸 약물 시장은 제형에 따라 점안액, 눈 연고 및 기타로 구분됩니다.

구매 방식

  • 처방
  • 처방전 없이 구입 가능한(OTC)

구매 방식을 기준으로, 글로벌 핑게쿨룸 약물 시장은 처방약과 일반의약품(OTC)으로 구분됩니다.

약물 유형

  • 브랜드화
  • 제네릭

인구 유형을 기준으로, 글로벌 핑게쿨룸 약물 시장은 브랜드 제품과 제네릭 제품으로 구분됩니다.

인구 유형

  • 노인
  • 성인

인구 유형을 기준으로, 글로벌 핑게쿨룸 약물 시장은 노인과 성인으로 구분됩니다.

최종 사용자

  • 병원
  • 전문 클리닉
  • 홈 헬스케어
  • 기타

글로벌 핑게쿨룸 약물 시장은 최종 사용자를 기준으로 병원, 전문 병원, 가정 건강 관리 및 기타로 구분됩니다.

유통 채널

  • 소매 약국
  • 병원 약국
  • 온라인 약국
  • 기타

핑게쿨룸 약물 시장

글로벌 핑게쿨룸 약물 시장은 유통 채널을 기준으로 소매 약국, 병원 약국, 온라인 약국 및 기타로 구분됩니다.

Pingueculum 약물 시장 지역 분석/통찰력

글로벌 핑게쿨룸 약물 시장을 분석하고, 위에 언급된 대로 국가, 약물 유형, 치료, 제형, 구매 방법, 인구 유형, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

세계 핑게쿨룸 약물 시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코, 러시아, 스페인, 터키, 독일, 이탈리아, 영국, 프랑스, ​​헝가리, 오스트리아, 스위스, 네덜란드, 폴란드, 아일랜드, 노르웨이, 리투아니아, 유럽의 다른 지역, 중국, 일본, 한국, 인도, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 베트남, 아시아 태평양의 다른 지역, 브라질, 아르헨티나, 페루, 남미의 다른 지역, 남아프리카 공화국, 사우디 아라비아, UAE, 이집트, 이스라엘, 쿠웨이트, 중동 및 아프리카의 다른 지역입니다.

아시아 태평양 지역은 눈 질환의 유병률을 낮추기 위한 이니셔티브와 계획으로 인해 글로벌 핑게쿨럼 약물 시장을 주도할 것으로 예상됩니다. 글로벌 핑게쿨럼 약물 시장은 열대 지역에서 핑게쿨럼의 유병률이 증가하고 노인 인구가 증가함에 따라 성장할 것으로 예상됩니다.

핑게쿨룸 약물 시장

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 글로벌 Pingueculum 약물 시장 점유율 분석

글로벌 핑게쿨럼 약물 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 글로벌 핑게쿨럼 약물 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 핑궤양 약물 시장에서 활동하는 주요 기업으로는 Alcon Inc., Johnson & Johnson Services, Inc., Novartis AG, Akorn Operating Company LLC, Bausch & Lomb Incorporated, AbbVie Inc., Prestige Consumer Healthcare Inc., Spectra Vision Care, Théa Laboratories, Wellona Pharma, SAGER PHARMA, Maya Biotech Private Limited, EYERIS VISIONCARE Pvt. Ltd., Sylentis, Bayer AG, Zydus Group, Amneal Pharmaceuticals LLC, OASIS Medical, Similasan Corporation, Alcon, Santen Pharmaceutical Co., Ltd. 등이 있습니다.

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가에게 전화를 요청하십시오.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 것을 자랑으로 생각합니다. 보고서는 타겟 브랜드의 가격 추세 분석, 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 타겟 경쟁업체의 시장 분석은 기술 기반 분석에서 시장 포트폴리오 전략까지 분석할 수 있습니다. 필요한 만큼 많은 경쟁업체를 원하는 형식과 데이터 스타일로 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 Excel 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용할 수 있는 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL PINGUECULUM DRUGS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 GLOBAL PINGUECULUM DRUGS MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 TREATMENT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET END-USER COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 EPIDERMIOLOGY

4.2 PESTEL ANALYSIS

4.3 PORTER’S FIVE FORCES

4.4 PIPELINE ANALYSIS FOR THE GLOBAL PINGUECULUM DRUGS MARKET

4.5 INDUSTRIAL INSIGHTS:

4.6 CONCLUSION:

5 GLOBAL PINGUECULUM DRUGS MARKET: REGULATIONS

 

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS

6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT

6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES

6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT

6.2 RESTRAINTS

6.2.1 STRINGENT RULES & REGULATIONS

6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT

6.3 OPPORTUNITIES

6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES

6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES

6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME

6.4 CHALLENGES

6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS

6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS

7 GLOBAL PINGUECULUM DRUGS MARKET, BY TREATMENT

7.1 OVERVIEW

7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS

7.2.1 DEMULCENT

7.2.2 EMOLLIENTS

7.3 STEROID EYE DROPS

7.3.1 KETONE STEROIDS

7.3.1.1 PREDNISOLONE

7.3.1.2 DEXAMETHASONE

7.3.1.3 FLUROMETHOLONE

7.3.1.4 MEDRYSONE

7.3.1.5 RIMEXOLONE

7.3.1.6 OTHERS

7.3.2 ESTER STEROID (LOTERPREDNOL)

7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS

7.5 OTHERS

8 GLOBAL PINGUECULUM DRUGS MARKET, BY FORMULATION

8.1 OVERVIEW

8.2 EYE DROPS

8.2.1 EYE DROPS WITH PRESERVATIVES

8.2.2 PRESERVATIVE-FREE EYE DROPS

 

8.3 EYE OINTMENTS

8.3.1 WITH PRESERVATIVES

8.3.2 PRESERVATIVE-FREE

8.3.3 OTHERS

8.4 OTHERS

9 GLOBAL PINGUECULUM DRUGS MARKET, MODE OF PURCHASE

9.1 OVERVIEW

9.2 PRESCRIPTION

9.3 OVER THE COUNTER (OTC)

10 GLOBAL PINGUECULUM DRUGS MARKET, BY DRUGS TYPE

10.1 OVERVIEW

10.2 BRANDED

10.3 GENERICS

11 GLOBAL PINGUECULUM DRUGS MARKET, BY POPULATION TYPE

11.1 OVERVIEW

11.2 GERIATRIC

11.2.1 MALE

11.2.2 FEMALE

11.3 ADULTS

11.3.1 MALE

11.3.2 FEMALE

12 GLOBAL PINGUECULUM DRUGS MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.3 SPECIALTY CLINICS

12.4 HOME HEALTHCARE

12.5 OTHERS

13 GLOBAL PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 RETAIL PHARMACIES

13.3 HOSPITAL PHARMACIES

13.4 ONLINE PHARMACIES

13.5 OTHERS

 

14 GLOBAL PINGUECULUM DRUGS MARKET, BY REGION

14.1 OVERVIEW

14.2 ASIA-PACIFIC

14.2.1 CHINA

14.2.2 INDIA

14.2.3 JAPAN

14.2.4 INDONESIA

14.2.5 SOUTH KOREA

14.2.6 AUSTRALIA

14.2.7 THAILAND

14.2.8 VIETNAM

14.2.9 PHILIPPINES

14.2.10 MALAYSIA

14.2.11 SINGAPORE

14.2.12 REST OF ASIA- PACIFIC

14.3 EUROPE

14.3.1 SPAIN

14.3.2 RUSSIA

14.3.3 TURKEY

14.3.4 GERMANY

14.3.5 ITALY

14.3.6 U.K.

14.3.7 FRANCE

14.3.8 HUNGARY

14.3.9 AUSTRIA

14.3.10 SWITZERLAND

14.3.11 NETHERLANDS

14.3.12 POLAND

14.3.13 IRELAND

14.3.14 NORWAY

14.3.15 LITHUANIA

14.3.16 REST OF EUROPE

14.4 NORTH AMERICA

14.4.1 U.S.

14.4.2 MEXICO

14.4.3 CANADA

 

14.5 SOUTH AMERICA

14.5.1 BRAZIL

14.5.2 ARGENTINA

14.5.3 PERU

14.5.4 REST OF SOUTH AMERICA

14.6 MIDDLE EAST AND AFRICA

14.6.1 SOUTH AFRICA

14.6.2 EGYPT

14.6.3 ISRAEL

14.6.4 U.A.E

14.6.5 SAUDI ARABIA

14.6.6 KUWAIT

14.6.7 REST OF MIDDLE EAST AND AFRICA

15 GLOBAL PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: GLOBAL

15.2 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15.3 COMPANY SHARE ANALYSIS: NORTH AMERICA

15.4 COMPANY SHARE ANALYSIS: EUROPE

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 ALCON INC.

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENT

17.2 ABBVIE INC.

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 COMPANY SHARE ANALYSIS

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENT

17.3 BAUSCH & LOMB INCORPORATED

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 COMPANY SHARE ANALYSIS

17.3.4 PRODUCT PORTFOLIO

17.3.5 RECENT DEVELOPMENT

17.4 BAYER AG

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 COMPANY SHARE ANALYSIS

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENTS

17.5 JOHNSON & JOHNSON VISION CARE, INC.

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 COMPANY SHARE ANALYSIS

17.5.4 PRODUCT PORTFOLIO

17.5.5 RECENT DEVELOPMENT

17.6 AKORN OPERATING COMPANY LLC

17.6.1 COMPANY SNAPSHOT

17.6.2 . PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 AMNEAL PHARMACEUTICALS LLC.

17.7.1 COMPANY SNAPSHOT

17.7.2 REVENUE ANALYSIS

17.7.3 PRODUCT PORTFOLIO

17.7.4 RECENT DEVELOPMENTS

17.8 EYERIS VISIONCARE PVT. LTD.

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENTS

17.9 LABORATOIRES THÉA

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENT

17.1 MAYA BIOTECH PRIVATE LIMITED

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENTS

17.11 NOVARTIS AG

17.11.1 COMPANY SNAPSHOT

17.11.2 REVENUE ANALYSIS

17.11.3 PRODUCT PORTFOLIO

17.11.4 RECENT DEVELOPMENT

 

17.12 OASIS MEDICAL, INC.

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENT

17.13 PRESTIGE CONSUMER HEALTHCARE, INC.

17.13.1 COMPANY SNAPSHOT

17.13.2 PRODUCT PORTFOLIO

17.13.3 RECENT DEVELOPMENT

17.14 SAGER PHARMA

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENTS

17.15 SANTEN PHARMACEUTICAL CO., LTD.

17.15.1 COMPANY SNAPSHOT

17.15.2 REVENUE ANALYSIS

17.15.3 PRODUCT PORTFOLIO

17.15.4 RECENT DEVELOPMENTS

17.16 SIMILASAN CORPORATION

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENTS

17.17 SPECTRA VISION CARE

17.17.1 COMPANY SNAPSHOT

17.17.2 PRODUCT PORTFOLIO

17.17.3 RECENT DEVELOPMENTS

17.18 SYLENTIS

17.18.1 COMPANY SNAPSHOT

17.18.2 PRODUCT PORTFOLIO

17.18.3 RECENT DEVELOPMENTS

17.19 WELLONA PHARMA

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENTS

17.2 ZYDUS GROUP

17.20.1 COMPANY SNAPSHOT

17.20.2 REVENUE ANALYSIS

17.20.3 PRODUCT PORTFOLIO

17.20.4 RECENT DEVELOPMENTS

 

18 QUESTIONNAIRE

19 RELATED REPORTS

표 목록

TABLE 1 GLOBAL PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 4 GLOBAL STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 GLOBAL STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 GLOBAL PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 10 GLOBAL EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 GLOBAL EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 GLOBAL PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 22 GLOBAL GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 GLOBAL GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 24 GLOBAL ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 GLOBAL ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 26 GLOBAL PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 27 GLOBAL HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 GLOBAL SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 GLOBAL HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 GLOBAL PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 32 GLOBAL RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 GLOBAL HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 GLOBAL ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 GLOBAL PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 38 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 39 ASIA-PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 40 ASIA-PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 ASIA-PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 42 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 43 ASIA-PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 44 ASIA-PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 47 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 48 ASIA-PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 49 ASIA-PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 50 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 51 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 52 CHINA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 53 CHINA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 CHINA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 CHINA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 CHINA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 57 CHINA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 58 CHINA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 59 CHINA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 60 CHINA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 61 CHINA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 62 CHINA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 63 CHINA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 64 CHINA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 65 CHINA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 66 INDIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 67 INDIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 68 INDIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 INDIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 INDIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 71 INDIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 72 INDIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 73 INDIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 74 INDIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 75 INDIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 76 INDIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 77 INDIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 78 INDIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 79 INDIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 80 JAPAN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 81 JAPAN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 JAPAN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 83 JAPAN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 84 JAPAN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 85 JAPAN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 86 JAPAN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 87 JAPAN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 88 JAPAN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 89 JAPAN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 90 JAPAN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 91 JAPAN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 92 JAPAN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 93 JAPAN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 94 INDONESIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 95 INDONESIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 96 INDONESIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 97 INDONESIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 INDONESIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 99 INDONESIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 100 INDONESIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 101 INDONESIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 102 INDONESIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 103 INDONESIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 104 INDONESIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 105 INDONESIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 106 INDONESIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 107 INDONESIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 108 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 109 SOUTH KOREA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 110 SOUTH KOREA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 111 SOUTH KOREA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 112 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 113 SOUTH KOREA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 114 SOUTH KOREA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 115 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 116 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 117 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 118 SOUTH KOREA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 119 SOUTH KOREA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 120 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 121 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 122 AUSTRALIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 123 AUSTRALIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 AUSTRALIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 AUSTRALIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 AUSTRALIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 127 AUSTRALIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 128 AUSTRALIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 129 AUSTRALIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 130 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 131 AUSTRALIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 132 AUSTRALIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 133 AUSTRALIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 134 AUSTRALIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 135 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 136 THAILAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 137 THAILAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 138 THAILAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 139 THAILAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 140 THAILAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 141 THAILAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 142 THAILAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 143 THAILAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 144 THAILAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 145 THAILAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 146 THAILAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 147 THAILAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 148 THAILAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 149 THAILAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 150 VIETNAM PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 151 VIETNAM ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 152 VIETNAM STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 153 VIETNAM KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 154 VIETNAM PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 155 VIETNAM EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 156 VIETNAM EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 157 VIETNAM PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 158 VIETNAM PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 159 VIETNAM PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 160 VIETNAM GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 161 VIETNAM ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 162 VIETNAM PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 163 VIETNAM PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 164 PHILIPPINES PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 165 PHILIPPINES ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 PHILIPPINES STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 167 PHILIPPINES KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 168 PHILIPPINES PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 169 PHILIPPINES EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 170 PHILIPPINES EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 171 PHILIPPINES PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 172 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 173 PHILIPPINES PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 174 PHILIPPINES GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 175 PHILIPPINES ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 176 PHILIPPINES PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 177 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 178 MALAYSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 179 MALAYSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 180 MALAYSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 181 MALAYSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 182 MALAYSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 183 MALAYSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 184 MALAYSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 185 MALAYSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 186 MALAYSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 187 MALAYSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 188 MALAYSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 189 MALAYSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 190 MALAYSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 191 MALAYSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 192 SINGAPORE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 193 SINGAPORE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 194 SINGAPORE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 195 SINGAPORE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 196 SINGAPORE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 197 SINGAPORE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 198 SINGAPORE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 199 SINGAPORE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 200 SINGAPORE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 201 SINGAPORE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 202 SINGAPORE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 203 SINGAPORE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 204 SINGAPORE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 205 SINGAPORE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 206 REST OF ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 207 EUROPE PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 208 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 209 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 211 EUROPE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 212 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 213 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 214 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 215 EUROPE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 216 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 217 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 218 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 219 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 220 EUROPE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 221 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 222 SPAIN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 223 SPAIN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 224 SPAIN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 225 SPAIN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 226 SPAIN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 227 SPAIN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 228 SPAIN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 229 SPAIN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 230 SPAIN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 231 SPAIN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 232 SPAIN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 233 SPAIN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 234 SPAIN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 235 SPAIN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 236 RUSSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 237 RUSSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 238 RUSSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 239 RUSSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 240 RUSSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 241 RUSSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 242 RUSSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 243 RUSSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 244 RUSSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 245 RUSSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 246 RUSSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 247 RUSSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 248 RUSSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 249 RUSSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 250 TURKEY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 251 TURKEY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 TURKEY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 253 TURKEY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 254 TURKEY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 255 TURKEY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 256 TURKEY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 257 TURKEY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 258 TURKEY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 259 TURKEY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 260 TURKEY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 261 TURKEY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 262 TURKEY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 263 TURKEY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 264 GERMANY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 265 GERMANY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 266 GERMANY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 267 GERMANY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 268 GERMANY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 269 GERMANY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 270 GERMANY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 271 GERMANY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 272 GERMANY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 273 GERMANY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 274 GERMANY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 275 GERMANY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 276 GERMANY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 277 GERMANY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 278 ITALY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 279 ITALY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 280 ITALY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 281 ITALY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 282 ITALY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 283 ITALY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 284 ITALY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 285 ITALY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 286 ITALY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 287 ITALY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 288 ITALY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 289 ITALY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 290 ITALY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 291 ITALY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 292 U.K. PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 293 U.K. ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 294 U.K. STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 295 U.K. KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 296 U.K. PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 297 U.K. EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 298 U.K. EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 299 U.K. PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 300 U.K. PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 301 U.K. PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 302 U.K. GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 303 U.K. ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 304 U.K. PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 305 U.K. PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 306 FRANCE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 307 FRANCE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 308 FRANCE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 309 FRANCE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 310 FRANCE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 311 FRANCE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 312 FRANCE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 313 FRANCE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 314 FRANCE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 315 FRANCE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 316 FRANCE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 317 FRANCE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 318 FRANCE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 319 FRANCE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 320 HUNGARY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 321 HUNGARY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 322 HUNGARY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 323 HUNGARY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 324 HUNGARY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 325 HUNGARY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 326 HUNGARY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 327 HUNGARY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 328 HUNGARY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 329 HUNGARY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 330 HUNGARY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 331 HUNGARY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 332 HUNGARY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 333 HUNGARY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 334 AUSTRIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 335 AUSTRIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 336 AUSTRIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 337 AUSTRIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 338 AUSTRIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 339 AUSTRIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 340 AUSTRIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 341 AUSTRIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 342 AUSTRIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 343 AUSTRIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 344 AUSTRIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 345 AUSTRIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 346 AUSTRIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 347 AUSTRIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 348 SWITZERLAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 349 SWITZERLAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 350 SWITZERLAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 351 SWITZERLAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 352 SWITZERLAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 353 SWITZERLAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 354 SWITZERLAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 355 SWITZERLAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 356 SWITZERLAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 357 SWITZERLAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 358 SWITZERLAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 359 SWITZERLAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 360 SWITZERLAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 361 SWITZERLAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 362 NETHERLANDS PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 363 NETHERLANDS ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 364 NETHERLANDS STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 365 NETHERLANDS KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 366 NETHERLANDS PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 367 NETHERLANDS EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 368 NETHERLANDS EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 369 NETHERLANDS PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 370 NETHERLANDS PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 371 NETHERLANDS PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 372 NETHERLANDS GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 373 NETHERLANDS ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 374 NETHERLANDS PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 375 NETHERLANDS PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 376 POLAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 377 POLAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 378 POLAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 379 POLAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 380 POLAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 381 POLAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 382 POLAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 383 POLAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 384 POLAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 385 POLAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 386 POLAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 387 POLAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 388 POLAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 389 POLAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 390 IRELAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 391 IRELAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 392 IRELAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 393 IRELAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 394 IRELAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 395 IRELAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 396 IRELAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 397 IRELAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 398 IRELAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 399 IRELAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 400 IRELAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 401 IRELAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 402 IRELAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 403 IRELAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 404 NORWAY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 405 NORWAY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 406 NORWAY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 407 NORWAY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 408 NORWAY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 409 NORWAY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 410 NORWAY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 411 NORWAY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 412 NORWAY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 413 NORWAY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 414 NORWAY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 415 NORWAY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 416 NORWAY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 417 NORWAY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 418 LITHUANIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 419 LITHUANIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 420 LITHUANIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 421 LITHUANIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 422 LITHUANIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 423 LITHUANIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 424 LITHUANIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 425 LITHUANIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 426 LITHUANIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 427 LITHUANIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 428 LITHUANIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 429 LITHUANIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 430 LITHUANIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 431 LITHUANIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 432 REST OF EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 433 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 434 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 435 NORTH AMERICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 436 NORTH AMERICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 437 NORTH AMERICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 438 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 439 NORTH AMERICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 440 NORTH AMERICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 441 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 442 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 443 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 444 NORTH AMERICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 445 NORTH AMERICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 446 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 447 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 448 U.S. PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 449 U.S. ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 450 U.S. STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 451 U.S. KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 452 U.S. PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 453 U.S. EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 454 U.S. EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 455 U.S. PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 456 U.S. PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 457 U.S. PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 458 U.S. GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 459 U.S. ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 460 U.S. PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 461 U.S. PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 462 MEXICO PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 463 MEXICO ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 464 MEXICO STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 465 MEXICO KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 466 MEXICO PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 467 MEXICO EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 468 MEXICO EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 469 MEXICO PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 470 MEXICO PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 471 MEXICO PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 472 MEXICO GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 473 MEXICO ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 474 MEXICO PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 475 MEXICO PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 476 CANADA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 477 CANADA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 478 CANADA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 479 CANADA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 480 CANADA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 481 CANADA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 482 CANADA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 483 CANADA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 484 CANADA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 485 CANADA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 486 CANADA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 487 CANADA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 488 CANADA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 489 CANADA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 490 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 491 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 492 SOUTH AMERICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 493 SOUTH AMERICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 494 SOUTH AMERICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 495 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 496 SOUTH AMERICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 497 SOUTH AMERICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 498 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 499 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 500 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 501 SOUTH AMERICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 502 SOUTH AMERICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 503 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 504 SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 505 BRAZIL PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 506 BRAZIL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 507 BRAZIL STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 508 BRAZIL KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 509 BRAZIL PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 510 BRAZIL EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 511 BRAZIL EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 512 BRAZIL PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 513 BRAZIL PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 514 BRAZIL PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 515 BRAZIL GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 516 BRAZIL ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 517 BRAZIL PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 518 BRAZIL PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 519 ARGENTINA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 520 ARGENTINA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 521 ARGENTINA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 522 ARGENTINA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 523 ARGENTINA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 524 ARGENTINA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 525 ARGENTINA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 526 ARGENTINA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 527 ARGENTINA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 528 ARGENTINA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 529 ARGENTINA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 530 ARGENTINA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 531 ARGENTINA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 532 ARGENTINA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 533 PERU PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 534 PERU ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 535 PERU STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 536 PERU KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 537 PERU PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 538 PERU EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 539 PERU EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 540 PERU PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 541 PERU PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 542 PERU PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 543 PERU GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 544 PERU ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 545 PERU PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 546 PERU PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 547 REST OF SOUTH AMERICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 548 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 549 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 550 MIDDLE EAST AND AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 551 MIDDLE EAST AND AFRICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 552 MIDDLE EAST AND AFRICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 553 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 554 MIDDLE EAST AND AFRICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 555 MIDDLE EAST AND AFRICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 556 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 557 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 558 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 559 MIDDLE EAST AND AFRICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 560 MIDDLE EAST AND AFRICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 561 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 562 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 563 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 564 SOUTH AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 565 SOUTH AFRICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 566 SOUTH AFRICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 567 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 568 SOUTH AFRICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 569 SOUTH AFRICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 570 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 571 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 572 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 573 SOUTH AFRICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 574 SOUTH AFRICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 575 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 576 SOUTH AFRICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 577 EGYPT PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 578 EGYPT ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 579 EGYPT STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 580 EGYPT KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 581 EGYPT PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 582 EGYPT EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 583 EGYPT EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 584 EGYPT PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 585 EGYPT PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 586 EGYPT PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 587 EGYPT GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 588 EGYPT ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 589 EGYPT PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 590 EGYPT PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 591 ISRAEL PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 592 ISRAEL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 593 ISRAEL STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 594 ISRAEL KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 595 ISRAEL PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 596 ISRAEL EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 597 ISRAEL EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 598 ISRAEL PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 599 ISRAEL PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 600 ISRAEL PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 601 ISRAEL GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 602 ISRAEL ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 603 ISRAEL PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 604 ISRAEL PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 605 UAE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 606 UAE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 607 UAE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 608 UAE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 609 UAE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 610 UAE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 611 UAE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 612 UAE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 613 U.A.E PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 614 UAE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 615 UAE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 616 UAE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 617 UAE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 618 UAE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 619 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 620 SAUDI ARABIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 621 SAUDI ARABIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 622 SAUDI ARABIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 623 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 624 SAUDI ARABIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 625 SAUDI ARABIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 626 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 627 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 628 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 629 SAUDI ARABIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 630 SAUDI ARABIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 631 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 632 SAUDI ARABIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 633 KUWAIT PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 634 KUWAIT ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 635 KUWAIT STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 636 KUWAIT KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 637 KUWAIT PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 638 KUWAIT EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 639 KUWAIT EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 640 KUWAIT PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 641 KUWAIT PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)

TABLE 642 KUWAIT PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 643 KUWAIT GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 644 KUWAIT ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 645 KUWAIT PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 646 KUWAIT PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 647 REST OF MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

그림 목록

FIGURE 1 GLOBAL PINGUECULUM DRUGS MARKET: SEGMENTATION

FIGURE 2 GLOBAL PINGUECULUM DRUGS MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL PINGUECULUM DRUGS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PINGUECULUM DRUGS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL PINGUECULUM DRUGS MARKET: DBMR POSITION GRID

FIGURE 8 GLOBAL PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 GLOBAL PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID

FIGURE 10 GLOBAL PINGUECULUM DRUGS MARKET: SEGMENTATION

FIGURE 11 ASIA-PACIFIC IS ANTICIPATED TO DOMINATE THE PINGUECULUM DRUGS MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE GLOBAL PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029

FIGURE 13 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE GLOBAL PINGUECULUM DRUGS MARKET FROM 2022 & 2029

FIGURE 14 ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR FOR PINGUECULUM DRUGS MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL PINGUECULUM DRUGS MARKET

FIGURE 16 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021

FIGURE 17 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION)

FIGURE 18 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029)

FIGURE 19 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 20 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021

FIGURE 21 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION)

FIGURE 22 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029)

FIGURE 23 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE

FIGURE 24 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021

FIGURE 25 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION)

FIGURE 26 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029)

FIGURE 27 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 28 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021

FIGURE 29 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION)

FIGURE 30 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029)

FIGURE 31 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE

FIGURE 32 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021

FIGURE 33 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION)

FIGURE 34 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029)

FIGURE 35 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 36 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, 2021

FIGURE 37 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 38 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 39 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 41 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 42 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 43 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 GLOBAL PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)

FIGURE 45 GLOBAL PINGUECULUM DRUGS MARKET: BY REGION (2021)

FIGURE 46 GLOBAL PINGUECULUM DRUGS MARKET: BY REGION (2022 & 2029)

FIGURE 47 GLOBAL PINGUECULUM DRUGS MARKET: BY REGION (2021 & 2029)

FIGURE 48 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)

FIGURE 49 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)

FIGURE 50 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)

FIGURE 51 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 52 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 53 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)

FIGURE 54 EUROPE PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)

FIGURE 55 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)

FIGURE 56 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 57 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 58 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)

FIGURE 59 NORTH AMERICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)

FIGURE 60 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)

FIGURE 61 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 62 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 63 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)

FIGURE 64 SOUTH AMERICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)

FIGURE 65 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)

FIGURE 66 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 67 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 68 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)

FIGURE 69 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)

FIGURE 70 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)

FIGURE 71 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 72 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 73 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)

FIGURE 74 GLOBAL PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)

FIGURE 75 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)

FIGURE 76 NORTH AMERICA PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)

FIGURE 77 EUROPE PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Pingueculum Drugs Market is anticipated to surge a 7.3% CAGR forecast by 2030.
The countries covered in the global pingueculum drugs market report are U.S., Canada, Mexico, Russia, Spain, Turkey, Germany, Italy, United Kingdom, France, Hungary, Austria, Switzerland, Netherlands, Poland, Ireland, Norway, Lithuania, Rest of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait and Rest of Middle East and Africa.
The Pingueculum Drugs Market report is segmented by Treatment, Formulation Type, Mode of Purchase, Drug Type, Population Type, End User & Distribution Channel
Asia-Pacific is expected to dominate the global pingueculum drugs because of initiatives and plans to lessen the prevalence of eye illness.

관련 페이지 탐색

Banner